top of page

NEWS RELEASE ARCHIVE

Ventripoint Diagnostics Provides a Corporate Update and Announces New Investor Relations Initiative

December 14, 2022

Ventripoint Signs on Arc Group Medical LLC as Distributor in Florida Region

November 30, 2022

Ventripoint Appoints MediTek Lifesciences LLC as Distributor for California

November 17, 2022

Ventripoint to Sponsor the Annual Meeting of the British Congenital Cardiac Association

November 4, 2022

Ventripoint Diagnostics Provides a Corporate Update and Announces New Investor Relations Initiative

October 27, 2022

Ventripoint Diagnostics Exhibiting at the 2022 British Society of Echocardiography

October 14, 2022

August 26, 2022

Ventripoint Announces Sponsorship for the European Society of Cardiology Congress 2022

August 26, 2022

Ventripoint Announces Sponsorship for the European Society of Cardiology Congress 2022

Ventripoint Annual General Meeting

August 16, 2022

August 10, 2022

Echocardiologists in Latin America Express Strong Interest in Ventripoint Whole Heart Analysis Products

June 29, 2022

Single Ventricle Congenital Heart Disease Study Launches at Leading Academic Medical Center using Ventripoint’s VMS+3.0 Whole-Heart Analysis System

June 7, 2022

Ventripoint Exhibiting at the American Society of Echocardiography 33rd Annual Scientific Session

May 17, 2022

Ventripoint Announces Sponsorship of the 55th Annual Meeting of the Association for European Paediatric and Congenital Cardiology

May 9, 2022

Ventripoint Hires Two Strategic Sales Account Managers for US, Europe, and UK Distribution

May 3, 2022

Ventripoint Announces Sponsorship for the 2022 SickKids Echo Symposium

April 27, 2022

Ventripoint Welcomes Dr. Jose Banchs as New Clinical Advisor

April 27, 2022

Ventripoint Welcomes Dr. Jose Banchs as New Clinical Advisor

April 19, 2022

Ventripoint Welcomes Dr. Howard Michael Leong-Poi as New Clinical Advisor

April 7, 2022

Ventripoint Signs on AngioConsult/Angiopro as European Distributor

April 1, 2022

Ventripoint to Exhibit at the American College of Cardiology 71st Annual Scientific Session and Expo and Correction to North Equities Corp Grant of Stock Options

March 21, 2022

March 21, 2022

March 21, 2022

March 21, 2022

March 21, 2022

Ventripoint Announces DTC Eligibility Approval in the U.S.

Ventripoint Announces DTC Eligibility Approval in the U.S.

March 21, 2022

Ventripoint Announces DTC Eligibility Approval in the U.S.

March 2, 2022

Ventripoint Hires Social Media Firm North Equities Corp.

March 1, 2022

Ventripoint and at the Mazankowski Heart Institute to Collaborate to Conduct a World-First Study of the Changes in Cardiac Function during Pregnancy

Ventripoint Appoints Dr. Gregory Skinner to Board of Clinical Advisors

February 2, 2022

February 3, 2022

Ventripoint Announces Sponsorship for 24th Annual Canadian Society of Echocardiography Echo Weekend

Ventripoint Hires Iconic Investor Relations LLC to Provide Investor Relations Services

January 27, 2022

Ventripoint Successfully Completes European Commission QMS Certification Surveillance Audit

January 24, 2022

January 21, 2022

Ventripoint Issues Option Grants and Reports Exercise of Options and Warrants

January 7, 2022

Ventripoint Announces Up-Listing to OTCQB Venture Market

December 28, 2021

Ventripoint Successfully Renews QMS Certification

December 21, 2021

Ventripoint Expands United Kingdom Marketing with New Distribution Partner CardioLogic

December 20, 2021

​Ventripoint Appoints Randy AuCoin to Board of Directors

November 22, 2021

Ventripoint Provides Corporate Update on Market Adoption of VMS+ Whole-heart Analysis System

November 9, 2021

Ventripoint Passes Audit of Manufacturing Facility for Canadian and US Markets

October 25, 2021

Ventripoint Appoints Fiona Fitzgerald To The Board Of Directors

October 21, 2021

Ventripoint Installs VMS+ 3.0 Unit at East Midlands Congenital Heart Centre

October 20, 2021

Ventripoint Diagnostics Ltd. Announces Closing of Upsized Bought Deal Offering of Units

October 13, 2021

Ventripoint Diagnostics Ltd. Announces Filing of Second Amended And Restated MD&A

October 1, 2021

Ventripoint Diagnostics Ltd. Announces Filing of Amended And Restated Interim Financial Statements And MD&A

September 28, 2021

Ventripoint Diagnostics Ltd. Announces Upside To Previously Announces Bought Deal Offering Of Units To $7 Million

September 27, 2021

Ventripoint Diagnostics Ltd. Announces $5 Million Bought Deal Offering of Units

September 17, 2021

Ventripoint Issues Option Grants to Consultant

Ventripoint Provides Update on Clinical Studies

September 15, 2021

Ventripoint Issues Option Grants to Consultants and Reports Options Exercise

September 14, 2021

Ventripoint Provides Update on Growth Initiatives and Sales

Ventripoint Issues Option Grants to Consultants and Reports Options Exercise

September 7, 2021

Ventripoint Reports Second Quarter 2021 Financial Statements and MD&A

September 3, 2021

Ventripoint Announces Patent Application for Improved Heart Analysis

August 9, 2021

Ventripoint Engages Digital257 for Social Media and Investor Relations Services

July 5, 2021

May 21, 2021

Ventripoint Announces Sponsorship for the 54th Annual Meeting of the Association of European Paediatric and Congenital Cardiology

Ventripoint Also Provides a Financial Update

Ventripoint Issues Option Grants to Consultants and a Director of the Corporation

July 2, 2021

May 21, 2021

Ventripoint Announces Sponsorship for the 54th Annual Meeting of the Association of European Paediatric and Congenital Cardiology

May 21, 2021

May 6, 2021

Ventripoint update on its Financial Status and on Warrant and Option Exercises

May 4, 2021

Ventripoint Receives Government Funding To Advance Development of Next Generation of VMS+

April 27, 2021

Ventripoint Collaborates with GE Healthcare to Bring More Functionality to its Cardiac Ultrasound Devices

April 26, 2021

Ventripoint Attends 23rd Annual Canadian Echo Weekend and Grants Stock Options

March 9, 2021

Ventripoint Passes Regulatory Inspection of Manufacturing Facility and Audit of Quality Assurance System

March 3, 2021

Ventripoint Diagnostics Receives Additional Wage Subsidy Assistance and
Updates Warrant Exercises

March 3, 2021

April 19, 2021

Ventripoint Extends Patent Portfolio with Foundational U.S. Provisional Patent Filing of Heart Motion Tracking Technology

April 15, 2021

Ventripoint Announces Sponsorship for the 2021 Canadian Society of Echocardiography Weekend Conference

April 13, 2021

Ventripoint Diagnostics Begins Publication of Case Studies Showing Meritorious
Use of the VMS Heart Analysis System

March 16, 2021

Ventripoint JV Begins Process to have Heart Analysis System Certified for use in
COVID Patients in China

March 2, 2021

Ventripoint JV Begins Training Chinese Cardiologists in Heart Analysis System and Achieves Milestone of First Commercial Sales

February 25, 2021

Correction - Ventripoint Diagnostics Issues Shares in Final Payment of
Debenture Interest

February 23, 2021

Ventripoint Heart Analysis System to be used at the Stollery Children’s Hospital to Study Atrial Dysfunction in Children

February 16, 2021

Ventripoint Advances Sales, Marketing, and Distribution Partnership in the
Largest Market in World for Heart Disease: China

February 9, 2021

Ventripoint Diagnostics Upgrades Investor Relations Webpage

February 10, 2021

Ventripoint Diagnostics Issues Shares in Final Payment of Debenture
Interest

February 8, 2021

Correction: Ventripoint Accelerated Expiry Date of Warrants

November 26, 2020

February 5, 2021

February 8, 2021

Ventripoint Issues Option Grants

Ventripoint Hires MarketSmart Communications to Provide Investor Relations Services

February 5, 2021

Ventripoint Announces Complete Conversion of Secured Convertible Debentures,Exercise of Warrants and Accelerated Expiry Date of Warrants

February 3, 2021

Ventripoint Diagnostics Issues Shares in Payment of Debenture Interest, Consulting Fees and DSU Exercise

Ventripoint Issues Option Grants and Exercises

January 28, 2021

Ventripoint Diagnostics Issues Shares in Payment of Consulting Fees

January 18, 2021

January 13, 2021

Ventripoint Announces Filing of Articles of Amendment

December 14, 2020

Ventripoint Diagnostics Receives Loan from FedDev Regional Relief and Recovery Fund and Reminds Shareholders about Annual General Meeting Today

November 26, 2020

Ventripoint Annual General Meeting

December 10, 2020

November 26, 2020

Ventripoint Diagnostics Issues Shares in Payment of Debenture Interest, Consulting Fees and DSU Exercise

December 10, 2020

Ventripoint Diagnostics Receives Wage Subsidy

January 13, 2021

Ventripoint Issues Option Grants

January 11, 2021

Ventripoint Expands to Address the Needs of Companion Animals

January 4, 2021

Kings College London Receives VMS+3.0 Ventripoint Whole Heart Analysis System

December 15, 2020

Ventripoint Diagnostics Reports Results of Annual General & Special Shareholders Meeting

October 9, 2020

Ventripoint Makes Application to Amend Warrants

October 8, 2020

Ventripoint Installs Whole Heart Analysis System in MD Anderson Cancer Center

September 30, 2020

Ventripoint Announces Appointment to the Board of Directors and Option Grants

September 28, 2020

Ventripoint Remotely Installs Whole Heart Analysis in Major European Hospital

September 25, 2020

Ventripoint Engages Torrey Hill Capital to Provide Investor Relations Services

Ventripoint To Resume Trading at the Market Opening Friday, September 25, 2020

September 23, 2020

September 15, 2020

Ventripoint Provides Corporate Update and Enters Review by TSXV to Resume Trading

September 14, 2020

Ventripoint Announces Closing of Second Tranche of Non-Brokered Secured Convertible Debenture Unit Private Placement  

September 15, 2020

​​Ventripoint Diagnostics Announces U.S. FDA Clearance for VMS+ 3.0 Whole Heart Analysis System

October 17, 2019

St. Michael's Hospital to Receive VMS+ 3.0 Whole Heart Analysis System

October 16, 2019

DOWNLOAD PDF
bottom of page